Medical research set to examine statins and dementia

MELBOURNE: A major medical trial will examine whether cholesterol-busting wonder drugs can also combat conditions such as dementia is underway.

The groundbreaking study of ­statins, backed by federal government cash as part of a $526 million boost for medical ­research projects, is set to be one of the world’s largest.

A five-year research funding plan will be announced today by Health Minister Greg Hunt. More than 680 new ­National Health and Medical ­Research Council grants also include a $61 million ­investment in heart disease and $86 million for ­cancer work.

A Monash University team will work to determine whether statins — the nation’s most prescribed drug for heart disease — also have benefits for elderly Australians at risk of a host of conditions.

About 40 per cent of Australians over 65 use statins, but most research has focused on males aged in their 50s facing heart issues. There are ­indications that the drugs have ­benefits in other areas as users age.

While the study will examine the drugs’ impact on heart disease in the over-70s, Professor Sophia Zoungas of Monash said it would be the first to also examine wider health impacts.

“The other outcome, which we think is much more important for this older population, is common geriatric syndromes that affect independence and quality of life, such as dementia and disability,” Prof Zoungas said.

“There is not enough evidence to make a clear decision one way or ­another regarding benefit or risk. We are trying to understand if there are any likely benefits and whether they outweigh any likely risks.”

“We think we need to know the risk-benefit balance across a broad range of conditions,” Prof Zoungas said.

“As you get older, you are not just worried about your heart — you are worried about your brain, you are worried about your physical function, and you want to ensure that you are ­independent in your own home,” she added.

The Statins in Reducing Events in the Elderly study, known as STAREE, first came about in 2015, but it will now ramped up by the $5.8 million NHMRC grant, allowing it to recruit and follow 10,000 Australians aged over 70 who have none of the conditions which would otherwise see them prescribed ­those drugs.

Other research grants to be awarded today, including ­almost $76 million for Monash University, will also see $41 million directed to mental health projects, $29 million for diabetes, $28 million towards obesity and $25 million ­focused on improving the health outcomes of indigenous Australians.

Mr Hunt said the projects supported across the nation ­included cutting-edge ideas such as vaccine development and tackling antimicrobial ­resistance.

“These grants will support our health and medical ­research workforce, providing greater opportunities for more life-changing medical breakthroughs,” Mr Hunt said.

“Health and medical ­research is one of the four ­pillars of the government’s long-term national health plan. Our government is committed to strengthening health and medical research.”